1.	A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CR005143, EPOANE3010, 2005-001817-17, NCT00338286
2.	Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 20070782, NCT00858364
3.	The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS) Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: AZA-MDS-003, 2012-002471-34, NCT01566695
4.	Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ACE-011-MDS-001, NCT01736683
5.	Lenalidomide and Eltrombopag in Low and Intermediate Risk MDS Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: 2012-407, 115479, RV--MDS-PI-0645, NCT01772420
6.	A Phase 1 Study of LY2787106 in Cancer and Anemia Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13131, I3S-MC-JABA, NCT01340976
7.	Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 12D.214, 2012-35, NCT01660347